TREVQ yields 2000000.00% · JNJ yields 2.13%● Live data
📍 TREVQ pulled ahead of the other in Year 1
Combined, TREVQ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TREVQ + JNJ for your $10,000?
Trevali Mining Corporation, a base-metals mining company, engages in the acquisition, exploration, development of, and production from mineral properties. It primarily explores for zinc, lead, silver, copper, and gold deposits. The company's operational assets include the 90%-owned Perkoa Mine in Burkina Faso; 90%-owned Rosh Pinah Mine in Namibia; and Caribou Mine in northern New Brunswick, Canada. It also holds interests in the Halfmile, Stratmat, and Restigouche properties situated in New Brunswick, Canada; Gergarub project in Namibia; and Ruttan Mine located in northern Manitoba, Canada. In addition, the company has an option to acquire a 100% interest in the Heath Steele deposit located in New Brunswick, Canada. Trevali Mining Corporation was formerly known as Trevali Resources Corp. and changed its name to Trevali Mining Corporation in April 2011. The company was incorporated in 1964 and is headquartered in Vancouver, Canada.
Full TREVQ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.